000 01284 a2200349 4500
005 20250514192442.0
264 0 _c20041216
008 200412s 0 0 eng d
022 _a1462-2416
024 7 _a10.1517/14622416.5.5.553
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLanfear, David E
245 0 0 _aFrequency of compound genotypes associated with beta-blocker efficacy in congestive heart failure.
_h[electronic resource]
260 _bPharmacogenomics
_cJul 2004
300 _a553-8 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAdrenergic beta-Antagonists
_xtherapeutic use
650 0 4 _aBlack or African American
_xgenetics
650 0 4 _aChi-Square Distribution
650 0 4 _aEurope
650 0 4 _aGene Frequency
_xgenetics
650 0 4 _aGenotype
650 0 4 _aHeart Failure
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aWhite People
_xgenetics
700 1 _aMarsh, Sharon
700 1 _aCresci, Sharon
700 1 _aSpertus, John A
700 1 _aMcLeod, Howard L
773 0 _tPharmacogenomics
_gvol. 5
_gno. 5
_gp. 553-8
856 4 0 _uhttps://doi.org/10.1517/14622416.5.5.553
_zAvailable from publisher's website
999 _c14917912
_d14917912